2011 Annual Meeting

Session: Protein Engineering I - Therapeutics

Chair

Karl E. Griswold, Dartmouth College

Presentations

08:30 AM

(256a) The Exploitation of S. Cerevisiae - Improved Understanding and Optimal Yields of Single-Chain Antibody Fragment (scFv) 4-4-20
Zachary T. Britton, Ronald W. Maurer, Anne S. Robinson

08:50 AM

(256b) Engineering Anti-Prion Scfv for the Treatment of Prion Diseases
Ryan J. O'Boyle

09:10 AM

(256c) Protease-Activated Antibodies for Diagnostics and Therapy
Tobias Schoep

09:30 AM

(256d) Engineered Monospecific and Bispecific Proteins That Target Tumor Vascular Receptors As In Vivo Imaging Agents
Sarah J. Moore, Cheuk L. Leung, Heidi Norton, Niv Papo, Jennifer R. Cochran

10:00 AM

(256e) A Protein Therapeutic Modality Founded On Molecular Regulation
Marc Ostermeier, Chapman M. Wright, R. Clay Wright, James R. Eshleman

10:20 AM

(256f) Transferrin Mediated Drug Delivery to Brain
Divya Chandra, Pankaj Karande

10:40 AM

(256g) Protegrin Has Distinct Mechanisms of Action On Prokaryotes and Eukaryotes As Defined by Unique Morphological Changes
Katherine G. Volzing, Yiannis Kaznessis